When to restart blood thinners after polyp removal
Part of Blood & lymphatic, Digestive system clinical trials.
This trial looks at the best time to restart direct oral anticoagulants (blood thinners) after having polyps removed during a colonoscopy. It aims to find a balance between preventing bleeding and reducing the risk of blood clots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are taking a direct oral anticoagulant (blood thinner like apixaban, rivaroxaban, edoxaban, or dabigatran)
- You are scheduled for a routine colonoscopy and may have polyps removed
- You have not had any part of your colon removed before
- You do not have inflammatory bowel disease (like Crohn's or ulcerative colitis) or a polyposis syndrome
- Your polyps can be removed without a complex procedure like endoscopic submucosal dissection (ESD)
- You do not have bleeding during the colonoscopy that requires immediate treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how safely and effectively to pause a blood thinner (a DOAC) for about 48 hours before an elective procedure in people with atrial fibrillation. It may help confirm the best way to reduce bleeding risk without raising stroke risk.
This study looks at how to safely restart blood thinners after a major gastrointestinal bleed, specifically for people with atrial fibrillation or blood clots. It aims to find the best timing and approach to prevent future strokes or clots while avoiding another bleed.
This study looks at the safest time to restart a blood thinner after a traumatic brain bleed. You will be placed in one of two groups: one that restarts the medicine early (about 1 week after the injury) and another that restarts it later (about 4 weeks after).
This trial tests whether placing small clips at the site of polyp removal in the colon can reduce bleeding in patients who take blood thinners afterwards.
This study compares whether you should temporarily stop your blood thinner (DOAC) or keep taking it when you have an elective heart catheter test or procedure (coronary angiography or PCI). It aims to see which approach is safer and better for preventing bleeding and clotting around the procedure.
This study looks at how to safely manage your blood thinner (DOAC) around the time of a planned, high-bleed-risk surgery or procedure involving a spinal needle. The goal is to find the best way to stop and restart your medication to prevent bleeding and clotting problems.
Hear when a new Postpolypectomy Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.